636 related articles for article (PubMed ID: 25924609)
1. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice.
Aida T; Chiyo K; Usami T; Ishikubo H; Imahashi R; Wada Y; Tanaka KF; Sakuma T; Yamamoto T; Tanaka K
Genome Biol; 2015 Apr; 16(1):87. PubMed ID: 25924609
[TBL] [Abstract][Full Text] [Related]
2. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing.
Hashimoto M; Takemoto T
Sci Rep; 2015 Jun; 5():11315. PubMed ID: 26066060
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
[TBL] [Abstract][Full Text] [Related]
4. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT; Weber T; Graf R; Sommermann T; Petsch K; Sack U; Volchkov P; Rajewsky K; Kühn R
BMC Biotechnol; 2016 Jan; 16():4. PubMed ID: 26772810
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs.
Ruan J; Li H; Xu K; Wu T; Wei J; Zhou R; Liu Z; Mu Y; Yang S; Ouyang H; Chen-Tsai RY; Li K
Sci Rep; 2015 Sep; 5():14253. PubMed ID: 26381350
[TBL] [Abstract][Full Text] [Related]
6. Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ.
Aida T; Nakade S; Sakuma T; Izu Y; Oishi A; Mochida K; Ishikubo H; Usami T; Aizawa H; Yamamoto T; Tanaka K
BMC Genomics; 2016 Nov; 17(1):979. PubMed ID: 27894274
[TBL] [Abstract][Full Text] [Related]
7. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
8. Generation of Pax6-IRES-EGFP knock-in mouse via the cloning-free CRISPR/Cas9 system to reliably visualize neurodevelopmental dynamics.
Inoue YU; Morimoto Y; Hoshino M; Inoue T
Neurosci Res; 2018 Jul; 132():1-7. PubMed ID: 29391173
[TBL] [Abstract][Full Text] [Related]
9. Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos.
Wang L; Shao Y; Guan Y; Li L; Wu L; Chen F; Liu M; Chen H; Ma Y; Ma X; Liu M; Li D
Sci Rep; 2015 Dec; 5():17517. PubMed ID: 26620761
[TBL] [Abstract][Full Text] [Related]
10. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
11. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9.
Zhang L; Jia R; Palange NJ; Satheka AC; Togo J; An Y; Humphrey M; Ban L; Ji Y; Jin H; Feng X; Zheng Y
PLoS One; 2015; 10(3):e0120396. PubMed ID: 25803037
[TBL] [Abstract][Full Text] [Related]
12. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
[TBL] [Abstract][Full Text] [Related]
13. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
[TBL] [Abstract][Full Text] [Related]
14. Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes.
Mashiko D; Young SA; Muto M; Kato H; Nozawa K; Ogawa M; Noda T; Kim YJ; Satouh Y; Fujihara Y; Ikawa M
Dev Growth Differ; 2014 Jan; 56(1):122-9. PubMed ID: 24372541
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells.
Kimura Y; Oda M; Nakatani T; Sekita Y; Monfort A; Wutz A; Mochizuki H; Nakano T
Sci Rep; 2015 Jun; 5():10710. PubMed ID: 26039937
[TBL] [Abstract][Full Text] [Related]
16. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
18. Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.
Zheng Q; Cai X; Tan MH; Schaffert S; Arnold CP; Gong X; Chen CZ; Huang S
Biotechniques; 2014; 57(3):115-24. PubMed ID: 25209046
[TBL] [Abstract][Full Text] [Related]
19. Intracellular generation of single-strand template increases the knock-in efficiency by combining CRISPR/Cas9 with AAV.
Xiao Q; Min T; Ma S; Hu L; Chen H; Lu D
Mol Genet Genomics; 2018 Aug; 293(4):1051-1060. PubMed ID: 29671068
[TBL] [Abstract][Full Text] [Related]
20. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the α-1,3-galactosyltransferase gene in porcine embryonic fibroblasts.
Sato M; Miyoshi K; Nagao Y; Nishi Y; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
Xenotransplantation; 2014; 21(3):291-300. PubMed ID: 24919525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
